Search results for " patients"
Article
Platform Technologies Improve Protein Expression
…ational modifications that meet the needs of the pharmaceutical industry, physicians, and ultimately patients in need of novel medications,” notes Bjørn Voldborg, director of CHO cell-line developmen…
Article
Bioburden Control in the Biopharmaceutical Industry
Microbial contamination and spoilage are among the most challenging problems that affect biologics manufacturers and patients. Thus, a continuous microbiological monitoring plan, coupled with SPC, sho…
Article
Process Chromatography: Continuous Optimization
There is a need for more economic downstream processes to ensure that modern therapeutic regimes can be offered to more patients worldwide,” observes Bulpin.
Adds Terova: “The landscape in molecul…
Article
The New World of Biopharmaceutical Manufacturing
Being able to provide consistent information from drug manufacturers to health authorities around the globe will ultimately favor the prompt launch of more medicines to meet the needs of many patients…
Article
Managing Risk in Biomanufacturing
With patients’ lives dependent on a continuous supply of high-quality drugs and vaccines, it is essential to have consistency within the industry on how to manage risks. Today’s business environment r…
Poster
Fast Trak Services: a collaborative project to accelerate downstream biosimilar process development
Biosimilars represent an innovative solution that can benefit both patients and healthcare systems by reducing the burden of rising treatment costs. To improve the availability, price and access of…
Article
Being Thorough When Transferring Technology
Communication and taking the time to develop the process are key to successful transfer and scale up of biologics.
By Susan Haigney
Editor's note: The following is an extended version of the…
Article
Speed and Flexibility Are Dual Goals for Biopharma Operations
Bioprocessing facilities, equipment, and materials, as well as strategies to improve biopharmaceutical development and manufacturing, were featured at INTERPHEX 2017, held in March in New York City.…
Article
Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
The ultimate beneficiary will be patients, who are likely to see reductions in the currently astronomical price of life-saving biologic therapies.
References
1. P.J. Declerk, Expert Opin. Biol…
Article
Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb Solution
Formation of protein aggregates and subvisible particles during the manufacturing of drug products are a major concern due to the potential immunogenicity of protein aggregates in patients (17–22). Th…